Cayman EZ Cap™ EGFP mRNA (mo5U)

EZ Cap™ EGFP mRNA encodes for enhanced GFP (EGFP), a variant of A. victoria GFP that contains chromophore mutations that increase the sensitivity of the protein and displays excitation and emission maxima of 489 and 511 nm, respectively.¹ It is capped using a co-transcriptional capping method, resulting in the naturally occurring Cap 1 structure with high capping efficiency. EZ Cap™ EGFP mRNA is also polyadenylated and modified with 5-methoxy-UTP (mo⁵U) to inhibit RNA-mediated innate immune activation. Encapsulation of EZ Cap™ EGFP mRNA (mo⁵U) in lipid nanoparticles (LNPs) can be used for mRNA delivery and expression of EGFP in vitro or in vivo.^2,3

WARNING This product is not for human or veterinary use.